14 Pharma Stocks Showing Upside Of Up To 28.54% Get 'Buy' Ratings

Leading brokerage house Parbhudas Lilladher has placed a 'buy' on 14 stocks that are part of pharmaceutical and healthcare sector. The companies either manufacturer medicinal drugs or operate a chain of hospital and healthcare facilities or a chain of pharmacists.

After these companies recently posted their quarterly performance, the stock-broking firm has set a target price for each of them based on the results and the management guidance. It feels that investing in them will provide decent returns in a few years.

These companies are showing a potential upside movement roughly between 8% to 29%. Given below are their details.

Company Name	Target Price (Rs/share)	Potential Upside (%)	Current Market Price (Rs/share)
Apollo Hospitals Enterprise	5,400	28.54	4,819
Aurobindo Pharma	660	8.02	662.60
Aster DM Healthcare	335	24.07	270.55
Eris Lifesciences	780	22.62	641.60
Fortis Healthcare	330	14.58	279.10
HealthCare Global Enterprises	375	27.55	322.25
Indoco Remedies	400	17.65	345.55
J.B. Chemicals & Pharmaceuticals	2,450	19.22	2,117.50
Cipla	1,070	14.19	964.25
Krishna Institute of Medical Sciences	660	8.71	1,597.40
Max Healthcare Institute	565	8.03	532.15
Narayana Hrudayalaya	980	18.5	907.25
Sun Pharmaceuticals	1,140	17.53	987.50
Torrent Pharmaceuticals	1,900	10.85	1,775.15

Disclaimer

The stocks have been picked from the brokerage report of Prabhudas Lilladher. Greynium Information Technologies, the author or the brokerage house will not be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.